KVUE Stock Rises As FDA Approves Tylenol Combination Despite Trump Administration’s Pushback

FDA approved KVUE's fixed-dose combination of acetaminophen and naproxen sodium as first OTC product of its kind.

The approval occurred despite pushback from the Trump administration.

KVUE stock rose following the FDA approval.